Traded Apr 14 · filed 2 days later
Derivative exercise or conversion — not an open-market buy.
Loading…
Traded Mar 16, 2026 · Filed Mar 17, 2026
The CFO of The Vita Coco sold $116K of The Vita Coco shares. The filing says it was made under a pre-arranged trading plan.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
open market sale
Code S — open-market or private sale
~$115,960
Shares × reported transaction price
26 days after results of Feb 18, 2026, 44 days before results of Apr 29, 2026
Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results
Footnote references a pre-arranged trading plan (Rule 10b5-1)
Only flagged when a footnote says so; never inferred
| After | Stock | S&P 500 | Difference |
|---|---|---|---|
| 7 days | −3.6% | −0.7% | −2.9% |
| 30 days | −13.5% | +7.4% | −20.9% |
| 90 days | +50.1% | +13.4% | +36.6% |
| 180 days | −1.5% | +15.0% | −16.6% |
Past results only. Not a forecast.
Traded Apr 14 · filed 2 days later
Derivative exercise or conversion — not an open-market buy.
Martin Roper (Chief Executive Officer) sold ~$1.25M of The Vita Coco Company
Scheduled in advanceTraded Apr 15 · filed 1 day later
Derivative exercise or conversion — not an open-market buy.